Annual SG&A
$2.25 M
-$716.70 K-24.19%
31 December 2023
Summary:
China Pharma Holdings annual selling, general & administrative expenses is currently $2.25 million, with the most recent change of -$716.70 thousand (-24.19%) on 31 December 2023. During the last 3 years, it has fallen by -$1.79 million (-44.37%). CPHI annual SG&A is now -68.61% below its all-time high of $7.16 million, reached on 31 December 2011.CPHI Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$479.70 K
+$276.40 K+135.96%
30 September 2024
Summary:
China Pharma Holdings quarterly selling, general & administrative expenses is currently $479.70 thousand, with the most recent change of +$276.40 thousand (+135.96%) on 30 September 2024. Over the past year, it has increased by +$26.90 thousand (+5.94%). CPHI quarterly SG&A is now -78.39% below its all-time high of $2.22 million, reached on 31 December 2011.CPHI Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$164.02 M
-$4.74 M-2.98%
30 September 2024
Summary:
China Pharma Holdings TTM selling, general & administrative expenses is currently -$164.02 million, with the most recent change of -$4.74 million (-2.98%) on 30 September 2024. Over the past year, it has dropped by -$166.51 million (-6684.89%). CPHI TTM SG&A is now -137.71% below its all-time high of $7.21 million, reached on 31 March 2012.CPHI TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPHI Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.2% | +5.9% | -6684.9% |
| 3 y3 years | -44.4% | +9.9% | -5029.5% |
| 5 y5 years | -56.5% | -49.3% | -3854.5% |
CPHI Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -44.4% | at low | -59.8% | +136.0% | -36.5% | at low |
| 5 y | 5 years | -56.5% | at low | -75.4% | +136.0% | -563.7% | at low |
| alltime | all time | -68.6% | +2315.5% | -78.4% | +227.0% | -137.7% | at low |
China Pharma Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $479.70 K(+136.0%) | $2.23 M(+1.2%) |
| June 2024 | - | $203.30 K(-65.9%) | $2.20 M(-3.4%) |
| Mar 2024 | - | $596.60 K(-37.2%) | $2.28 M(+1.5%) |
| Dec 2023 | $2.25 M(-24.2%) | $949.30 K(+109.7%) | $2.25 M(-9.8%) |
| Sept 2023 | - | $452.80 K(+60.6%) | $2.49 M(-3.2%) |
| June 2023 | - | $281.90 K(-49.9%) | $2.57 M(-9.1%) |
| Mar 2023 | - | $562.40 K(-52.9%) | $2.83 M(-4.4%) |
| Dec 2022 | $2.96 M(-5.8%) | $1.19 M(+122.7%) | $2.96 M(+1.6%) |
| Sept 2022 | - | $536.00 K(-0.6%) | $2.92 M(+3.5%) |
| June 2022 | - | $539.50 K(-22.2%) | $2.82 M(-7.7%) |
| Mar 2022 | - | $693.70 K(-39.5%) | $3.05 M(-3.0%) |
| Dec 2021 | $3.15 M(-22.1%) | $1.15 M(+162.9%) | $3.15 M(-5.5%) |
| Sept 2021 | - | $436.30 K(-43.7%) | $3.33 M(-13.3%) |
| June 2021 | - | $775.20 K(-1.5%) | $3.84 M(-6.7%) |
| Mar 2021 | - | $787.30 K(-40.7%) | $4.11 M(+1.8%) |
| Dec 2020 | $4.04 M(-13.0%) | $1.33 M(+40.6%) | $4.04 M(-13.3%) |
| Sept 2020 | - | $944.70 K(-10.0%) | $4.66 M(-0.0%) |
| June 2020 | - | $1.05 M(+46.9%) | $4.66 M(+4.7%) |
| Mar 2020 | - | $714.70 K(-63.3%) | $4.45 M(-4.2%) |
| Dec 2019 | $4.64 M(-10.1%) | $1.95 M(+105.7%) | $4.64 M(+6.3%) |
| Sept 2019 | - | $946.90 K(+12.7%) | $4.37 M(-6.5%) |
| June 2019 | - | $840.40 K(-7.4%) | $4.67 M(-4.7%) |
| Mar 2019 | - | $907.50 K(-45.8%) | $4.90 M(-5.1%) |
| Dec 2018 | $5.17 M(-5.7%) | $1.67 M(+33.6%) | $5.17 M(-4.1%) |
| Sept 2018 | - | $1.25 M(+17.1%) | $5.39 M(+4.2%) |
| June 2018 | - | $1.07 M(-8.6%) | $5.17 M(-6.3%) |
| Mar 2018 | - | $1.17 M(-38.2%) | $5.52 M(+0.7%) |
| Dec 2017 | $5.48 M(-13.0%) | $1.90 M(+83.0%) | $5.48 M(-4.5%) |
| Sept 2017 | - | $1.04 M(-26.8%) | $5.74 M(-3.1%) |
| June 2017 | - | $1.42 M(+24.8%) | $5.93 M(-3.6%) |
| Mar 2017 | - | $1.13 M(-47.4%) | $6.15 M(-2.4%) |
| Dec 2016 | $6.30 M(+1.8%) | $2.15 M(+76.4%) | $6.30 M(+7.4%) |
| Sept 2016 | - | $1.22 M(-25.4%) | $5.87 M(-5.1%) |
| June 2016 | - | $1.64 M(+27.3%) | $6.18 M(+2.8%) |
| Mar 2016 | - | $1.29 M(-25.1%) | $6.02 M(-2.8%) |
| Dec 2015 | $6.19 M(+22.3%) | $1.72 M(+11.6%) | $6.19 M(+1.3%) |
| Sept 2015 | - | $1.54 M(+4.6%) | $6.11 M(+6.5%) |
| June 2015 | - | $1.47 M(+0.7%) | $5.74 M(+8.7%) |
| Mar 2015 | - | $1.46 M(-10.9%) | $5.28 M(+4.3%) |
| Dec 2014 | $5.06 M(-11.0%) | $1.64 M(+40.3%) | $5.06 M(-1.5%) |
| Sept 2014 | - | $1.17 M(+15.7%) | $5.14 M(-2.4%) |
| June 2014 | - | $1.01 M(-18.8%) | $5.27 M(-5.1%) |
| Mar 2014 | - | $1.24 M(-27.5%) | $5.55 M(-2.5%) |
| Dec 2013 | $5.69 M(-11.2%) | $1.72 M(+32.6%) | $5.69 M(+0.5%) |
| Sept 2013 | - | $1.29 M(+0.1%) | $5.66 M(-2.7%) |
| June 2013 | - | $1.29 M(-6.7%) | $5.82 M(-6.5%) |
| Mar 2013 | - | $1.39 M(-18.1%) | $6.22 M(-2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $6.41 M(-10.4%) | $1.69 M(+16.2%) | $6.41 M(-7.6%) |
| Sept 2012 | - | $1.45 M(-14.2%) | $6.94 M(-2.4%) |
| June 2012 | - | $1.69 M(+7.9%) | $7.11 M(-1.3%) |
| Mar 2012 | - | $1.57 M(-29.3%) | $7.21 M(+0.7%) |
| Dec 2011 | $7.16 M(+28.2%) | $2.22 M(+36.4%) | $7.16 M(+11.1%) |
| Sept 2011 | - | $1.63 M(-8.8%) | $6.44 M(+5.0%) |
| June 2011 | - | $1.79 M(+17.4%) | $6.14 M(+4.6%) |
| Mar 2011 | - | $1.52 M(+0.9%) | $5.87 M(+5.1%) |
| Dec 2010 | $5.58 M(+15.0%) | $1.51 M(+14.0%) | $5.58 M(+4.3%) |
| Sept 2010 | - | $1.32 M(-12.8%) | $5.35 M(-0.1%) |
| June 2010 | - | $1.52 M(+22.7%) | $5.36 M(+7.2%) |
| Mar 2010 | - | $1.24 M(-3.1%) | $5.00 M(+3.0%) |
| Dec 2009 | $4.85 M(+30.7%) | $1.28 M(-4.0%) | $4.85 M(+51.7%) |
| Sept 2009 | - | $1.33 M(+14.8%) | $3.20 M(-2.7%) |
| June 2009 | - | $1.16 M(+6.1%) | $3.29 M(-9.9%) |
| Mar 2009 | - | $1.09 M(-388.8%) | $3.65 M(-1.7%) |
| Dec 2008 | $3.71 M(+12.0%) | -$377.70 K(-126.7%) | $3.71 M(-19.3%) |
| Sept 2008 | - | $1.42 M(-6.8%) | $4.60 M(+16.9%) |
| June 2008 | - | $1.52 M(+31.8%) | $3.93 M(+33.7%) |
| Mar 2008 | - | $1.15 M(+127.3%) | $2.94 M(-11.3%) |
| Dec 2007 | $3.32 M(+125.0%) | $507.50 K(-32.4%) | $3.32 M(-11.9%) |
| Sept 2007 | - | $750.80 K(+41.8%) | $3.76 M(+13.8%) |
| June 2007 | - | $529.60 K(-65.3%) | $3.31 M(+0.3%) |
| Mar 2007 | - | $1.53 M(+59.9%) | $3.30 M(+55.4%) |
| Dec 2006 | $1.47 M(+496.8%) | $955.30 K(+223.0%) | $2.12 M(+81.9%) |
| Sept 2006 | - | $295.80 K(-43.0%) | $1.17 M(+0.6%) |
| June 2006 | - | $518.50 K(+47.2%) | $1.16 M(-52.0%) |
| Mar 2006 | - | $352.20 K(+21.8%) | $2.42 M(+13.9%) |
| Dec 2005 | $247.00 K(-86.6%) | - | - |
| Sept 2005 | - | $289.20 K(-83.7%) | $2.12 M(+15.1%) |
| June 2005 | - | $1.77 M(+4257.7%) | $1.84 M(+1805.3%) |
| June 2005 | $1.84 M(+1881.1%) | - | - |
| Mar 2005 | - | $40.70 K(+133.9%) | $96.70 K(+65.3%) |
| Dec 2004 | - | $17.40 K(+62.6%) | $58.50 K(+40.3%) |
| Sept 2004 | - | $10.70 K(-61.6%) | $41.70 K(-55.1%) |
| June 2004 | $93.00 K(-65.0%) | $27.90 K(+1016.0%) | $92.90 K(-57.6%) |
| Mar 2004 | - | $2500.00(+316.7%) | $219.00 K(-9.8%) |
| Dec 2003 | - | $600.00(-99.0%) | $242.70 K(-15.2%) |
| Sept 2003 | - | $61.90 K(-59.8%) | $286.10 K(+7.7%) |
| June 2003 | $265.70 K(-64.7%) | $154.00 K(+487.8%) | $265.70 K(+13.8%) |
| Mar 2003 | - | $26.20 K(-40.5%) | $233.50 K(-58.5%) |
| Dec 2002 | - | $44.00 K(+6.0%) | $562.50 K(-10.8%) |
| Sept 2002 | - | $41.50 K(-65.9%) | $630.80 K(-16.2%) |
| June 2002 | $752.30 K | $121.80 K(-65.7%) | $752.40 K(+19.3%) |
| Mar 2002 | - | $355.20 K(+216.3%) | $630.60 K(+129.0%) |
| Dec 2001 | - | $112.30 K(-31.1%) | $275.40 K(+68.9%) |
| Sept 2001 | - | $163.10 K | $163.10 K |
FAQ
- What is China Pharma Holdings annual selling, general & administrative expenses?
- What is the all time high annual SG&A for China Pharma Holdings?
- What is China Pharma Holdings annual SG&A year-on-year change?
- What is China Pharma Holdings quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for China Pharma Holdings?
- What is China Pharma Holdings quarterly SG&A year-on-year change?
- What is China Pharma Holdings TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for China Pharma Holdings?
- What is China Pharma Holdings TTM SG&A year-on-year change?
What is China Pharma Holdings annual selling, general & administrative expenses?
The current annual SG&A of CPHI is $2.25 M
What is the all time high annual SG&A for China Pharma Holdings?
China Pharma Holdings all-time high annual selling, general & administrative expenses is $7.16 M
What is China Pharma Holdings annual SG&A year-on-year change?
Over the past year, CPHI annual selling, general & administrative expenses has changed by -$716.70 K (-24.19%)
What is China Pharma Holdings quarterly selling, general & administrative expenses?
The current quarterly SG&A of CPHI is $479.70 K
What is the all time high quarterly SG&A for China Pharma Holdings?
China Pharma Holdings all-time high quarterly selling, general & administrative expenses is $2.22 M
What is China Pharma Holdings quarterly SG&A year-on-year change?
Over the past year, CPHI quarterly selling, general & administrative expenses has changed by +$26.90 K (+5.94%)
What is China Pharma Holdings TTM selling, general & administrative expenses?
The current TTM SG&A of CPHI is -$164.02 M
What is the all time high TTM SG&A for China Pharma Holdings?
China Pharma Holdings all-time high TTM selling, general & administrative expenses is $7.21 M
What is China Pharma Holdings TTM SG&A year-on-year change?
Over the past year, CPHI TTM selling, general & administrative expenses has changed by -$166.51 M (-6684.89%)